Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic
NCT ID: NCT00358033
Last Updated: 2014-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
200 participants
INTERVENTIONAL
2003-07-31
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
NCT00357955
Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes
NCT00409240
Reducing CVD Risk in African Americans Faith Communities
NCT02235896
Reducing Total Cardiovascular Risk in an Urban Community
NCT00241904
Enhancing Support for Women at Risk for Heart Disease
NCT00142701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group intervention
pharmacist-led group intervention in behavioral and pharmacologic therapy
Counseling
Interactive Education
Group Support
Pharmacologic case management
Provided by clinical pharmacists
individual
pharmacist-based individual clinic visits with behavioral and pharmacologic intervention for cardiac risk reduction
Counseling
Pharmacologic case management
Provided by clinical pharmacists
usual care
usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Counseling
Interactive Education
Group Support
Pharmacologic case management
Provided by clinical pharmacists
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible for CRRC discharge:
1. For DM patients:
* HbA1c \< 7.0 %,
* BP \< 130/85 mm Hg , and
* LDL \< 100 mg/dl;
2. For Non-DM patients:
* BP \< 140/90 mm Hg, and
* LDL \< 100 mg/dl;
* Able and willing to sign informed consent.
Exclusion Criteria
* Metastatic disease or terminal illness
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
Providence VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wen-Chih Wu
Staff Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wen-Chih Wu, MD
Role: PRINCIPAL_INVESTIGATOR
Providence VAMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Providence VAMC
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12712
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.